cardiac glycosides (Harvard University/Harvard University Office of Technology Development)

N/A

Report date: 2025/03/17 09:44:25
NME

Base Information

Drug Namecardiac glycosides (Harvard University/Harvard University Office of Technology Development)
Drug Alias Namebufalinbufalin (Harvard University/Harvard University Office of Technology Development)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterferon beta inhibitors
TargetsInterferon beta
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHarvard University
China Registration ClassN/A

Develop Information

Active CompaniesHarvard University
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A